These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 11120014)

  • 21. Impact of hepatitis C virus infection on patient and graft survival in kidney transplantation.
    Manga Sahin G; Sahin S; Kantarci G; Ergin H
    Transplant Proc; 2006 Mar; 38(2):499-501. PubMed ID: 16549159
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A case of renal transplantation received from a living donor with second-generation anti-hepatitis C virus antibody positive into an anti-hepatitis C virus antibody negative recipient.
    Watanabe T; Koyama I; Shinozuka N; Mochida S; Ozawa S; Minoshima T; Nagashima N; Matsumoto T; Anzai H; Kyo S
    Transplant Proc; 2000 Nov; 32(7):1593-4. PubMed ID: 11119851
    [No Abstract]   [Full Text] [Related]  

  • 23. Risk of acute cellular rejection after azathioprine withdrawal in stable renal allograft recipients on cyclosporine, azathioprine, and prednisone.
    Fabrega AJ; Roy G; Reynolds L; Corwin C; Hunsicker L
    Transplant Proc; 1998 Jun; 30(4):1335-6. PubMed ID: 9636543
    [No Abstract]   [Full Text] [Related]  

  • 24. A late episode of post-transplant diabetes mellitus during active hepatitis C infection in a renal allograft recipient using tacrolimus.
    van Duijnhoven EM; Christiaans MH; Boots JM; Goossens VJ; Undre NA; van Hooff JP
    Am J Kidney Dis; 2002 Jul; 40(1):195-201. PubMed ID: 12087579
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High incidence of proteinuria in hepatitis C virus-infected renal transplant recipients is associated with poor patient and graft outcome.
    Nampoory MR; Johny KV; Costandi JN; Said T; Abraham M; Gupta RK; El-Reshaid W; Al-Muzeirei I; Samhan M; Al-Mousawi M
    Transplant Proc; 2001 Aug; 33(5):2791-5. PubMed ID: 11498162
    [No Abstract]   [Full Text] [Related]  

  • 26. Impact of presence of HBs antigen and anti-hepatitis C virus and anti-cytomegalovirus antibodies on transplanted kidney survival.
    Sieńko J; Wiśniewska M; Ciechanowski K; Rózański J; Domański L; Myslak M; Kamiński M; Sulikowski T; Pabisiak K; Romanowski M; Mizerski A; Tejchman K; Nowacki M; Ostrowski M; Bohatyrewicz R
    Transplant Proc; 2006; 38(1):136-8. PubMed ID: 16504685
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of partial HLA class I match on acute rejection in viral pre-infected human liver allograft recipients.
    Ontañón J; Muro M; García-Alonso AM; Minguela A; Torío A; Bermejo J; Pons JA; Campos M; Alvarez-López MR
    Transplantation; 1998 Apr; 65(8):1047-53. PubMed ID: 9583864
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence and clinical course of hepatitis B and hepatitis C liver disease in ciclosporin-treated renal allograft recipients.
    Bang BK; Yang CW; Yoon SA; Kim YS; Chang YS; Yoon YS; Koh YB
    Nephron; 1995; 70(4):397-401. PubMed ID: 7477642
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mycophenolate mofetil in living donor renal allograft recipients.
    Park K; Moon JI; Kim SI; Kim YS
    Transplant Proc; 1999; 31(1-2):1133. PubMed ID: 10083506
    [No Abstract]   [Full Text] [Related]  

  • 30. Clinical course of hepatitis C virus infection in renal transplant recipients.
    Savas N; Ocal S; Colak T; Karakayali H; Yilmaz U; Haberal M
    Transplant Proc; 2007 May; 39(4):984-6. PubMed ID: 17524869
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of mycophenolate mofetil in kidney transplant recipients with viral hepatitis infection: is it justified?
    Sumethkul V; Ingsathit A; Leelasa-Nguan P; Jirasiritham S
    Transplant Proc; 2002 Dec; 34(8):3217-9. PubMed ID: 12493425
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of hypertension, hyperlipidemia and cyclosporine A therapy on long-term renal allograft survival.
    Maeda H; Sakamoto K; Kashiwabara H; Hachisu T; Yamada H; Matsushita K; Yamada K; Yokoyama T
    Transplant Proc; 1996 Jun; 28(3):1633-4. PubMed ID: 8658816
    [No Abstract]   [Full Text] [Related]  

  • 33. Clinical implication of the presence of hepatitis C virus antibodies after kidney transplantation in Japan.
    Tomikawa S; Ito S; Kikuchi K; Ando Y; Ichikawa N; Meigata K; Nomura Y; Watanabe K; Degawa H; Beck Y; Nagao T; Uchida H
    Transplant Proc; 1996 Jun; 28(3):1498-500. PubMed ID: 8658758
    [No Abstract]   [Full Text] [Related]  

  • 34. Chronic rejection in cyclosporin A treated renal allograft recipients with allopeptide reactive T cells.
    Iniotaki-Theodoraki A; Boletis J; Stamatiadis D; Choremi H; Kostakis A
    Transplant Proc; 1999; 31(1-2):1168-70. PubMed ID: 10083522
    [No Abstract]   [Full Text] [Related]  

  • 35. Impact of hepatitis C virus infection on short-term outcome in renal transplantation: a single-center study.
    Sabet S; Hakemi M; Nadjafi I; Ganji MR; Argani H; Broumand B
    Transplant Proc; 2003 Nov; 35(7):2699-700. PubMed ID: 14612080
    [No Abstract]   [Full Text] [Related]  

  • 36. Clinical outcome of HCV infection after renal transplantation.
    Kokado Y; Takahara S; Ichimaru N; Toki K; Wang JD; Permpongkosol S; Sagawa S; Ichikawa Y; Akiyama T; Yoshimura N; Okuyama A
    Transplant Proc; 2000 Nov; 32(7):1940-3. PubMed ID: 11120011
    [No Abstract]   [Full Text] [Related]  

  • 37. Improved clinical outcomes in Chinese renal allograft recipients receiving lower dose immunosuppressants.
    Wu JY; Chen JH; Wang YM; He Q; Wu DB
    Transplantation; 2004 Sep; 78(5):713-8. PubMed ID: 15371674
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of hepatitis C virus on renal transplantation: association with poor survival.
    Pedroso S; Martins L; Fonseca I; Dias L; Henriques AC; Sarmento AM; Cabrita A
    Transplant Proc; 2006; 38(6):1890-4. PubMed ID: 16908314
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term outcome in simultaneous kidney and pancreas transplant recipients with functioning allografts at 1-year posttransplantation.
    Peddi VR; Munda R; Demmy AM; First MR
    Transplant Proc; 1999; 31(1-2):608-9. PubMed ID: 10083257
    [No Abstract]   [Full Text] [Related]  

  • 40. Proteinuria at five years after kidney transplantation: the role of anti-HCV-positive state.
    Virgilio B; Palminteri G; Maresca MC; Brunello A; Calconi G; Vianello A
    Transplant Proc; 2001; 33(7-8):3639-40. PubMed ID: 11750545
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.